MX2010003009A - Piridil sulfonamidas como moduladores de canales ionicos. - Google Patents

Piridil sulfonamidas como moduladores de canales ionicos.

Info

Publication number
MX2010003009A
MX2010003009A MX2010003009A MX2010003009A MX2010003009A MX 2010003009 A MX2010003009 A MX 2010003009A MX 2010003009 A MX2010003009 A MX 2010003009A MX 2010003009 A MX2010003009 A MX 2010003009A MX 2010003009 A MX2010003009 A MX 2010003009A
Authority
MX
Mexico
Prior art keywords
ion channels
modulators
pyridyl
sulfonamides
pyridyl sulfonamides
Prior art date
Application number
MX2010003009A
Other languages
English (en)
Inventor
Esther Martinborough
Timothy Neubert
Nicole Zimmermann
Tara Leanne Hampton
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of MX2010003009A publication Critical patent/MX2010003009A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

La presente invenci?n se relaciona con derivados de piridilsulfonamida ?tiles como inhibidores de los canales i?nicos. La invenci?n tambi?n proporciona composiciones farmac?uticamente aceptables que comprenden los compuestos de la invenci?n y con m?todos para usar las composiciones en el tratamiento de diferentes trastornos.
MX2010003009A 2007-09-19 2008-09-19 Piridil sulfonamidas como moduladores de canales ionicos. MX2010003009A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99442307P 2007-09-19 2007-09-19
PCT/US2008/076928 WO2009039328A1 (en) 2007-09-19 2008-09-19 Pyridyl sulfonamides as modulators of ion channels

Publications (1)

Publication Number Publication Date
MX2010003009A true MX2010003009A (es) 2010-04-30

Family

ID=40352214

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003009A MX2010003009A (es) 2007-09-19 2008-09-19 Piridil sulfonamidas como moduladores de canales ionicos.

Country Status (9)

Country Link
US (1) US7994174B2 (es)
EP (1) EP2201008A1 (es)
JP (1) JP2010539244A (es)
CN (1) CN101842372A (es)
AU (1) AU2008302205A1 (es)
CA (1) CA2699892A1 (es)
MX (1) MX2010003009A (es)
NZ (1) NZ584009A (es)
WO (1) WO2009039328A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615563B2 (en) * 2003-08-08 2009-11-10 Gonzalez Iii Jesus E Compositions useful as inhibitors of voltage-gated sodium channels
CA2607670A1 (en) 2005-05-10 2006-11-16 Vertex Pharmaceuticals Incorporated Bicyclic derivatives as modulators of ion channels
AU2006247478A1 (en) * 2005-05-16 2006-11-23 Vertex Pharmaceuticals Incorporated Bicyclic derivatives as modulators of ion channels
CN101300253B (zh) * 2005-09-09 2012-08-22 沃泰克斯药物股份有限公司 作为电压门控离子通道调控剂的二环衍生物
JP2009512717A (ja) * 2005-10-21 2009-03-26 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルを調節するための誘導体
US7799822B2 (en) * 2005-12-21 2010-09-21 Vertex Pharmaceuticals Incorporated Phenyl sulfonamides as modulators of ion channels
PE20130325A1 (es) 2007-04-27 2013-03-18 Purdue Pharma Lp Derivados de piperidina, piperazina o tetrahidropiridilo como antagonistas de trpv1
CN101687782A (zh) 2007-05-25 2010-03-31 沃泰克斯药物股份有限公司 离子通道调节剂及其使用方法
MX2010005309A (es) * 2007-11-13 2010-06-25 Vertex Pharma Derivados de 4-(3-(2-(fenil)morfolino)-2-oxopirrolidin-1-il-n-(tia zol-2-il)bencensulfonamida y compuestos relacionados como moduladores de canales ionicos para el tratamiento del dolor.
MX2010005307A (es) * 2007-11-13 2010-07-28 Vertex Pharma Derivados heterociclicos como moduladores de canales de iones.
US7846954B2 (en) * 2008-07-01 2010-12-07 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels
EP2480531B1 (en) * 2009-09-21 2014-11-05 ChemoCentryx, Inc. Pyrrolidinone carboxamide derivatives as chemerin-r (chemr23) modulators
UA113288C2 (xx) 2011-06-22 2017-01-10 Trpv1 антагоністи, що містять дигідроксизамісник, і їх застосування
PL2723710T3 (pl) 2011-06-27 2017-02-28 Newron Pharmaceuticals S.P.A. Fluorowane pochodne aryloalkiloaminokarboksyamidowe
US10510973B2 (en) * 2014-12-17 2019-12-17 Universal Display Corporation Color-stable organic light emitting diode stack
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615356B2 (en) 2000-07-10 2009-11-10 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
AU2004240885A1 (en) 2003-05-21 2004-12-02 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
US7615563B2 (en) * 2003-08-08 2009-11-10 Gonzalez Iii Jesus E Compositions useful as inhibitors of voltage-gated sodium channels
KR20060073930A (ko) * 2003-08-08 2006-06-29 버텍스 파마슈티칼스 인코포레이티드 통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
JP2007261945A (ja) 2004-04-07 2007-10-11 Taisho Pharmaceut Co Ltd チアゾール誘導体
CA2607670A1 (en) * 2005-05-10 2006-11-16 Vertex Pharmaceuticals Incorporated Bicyclic derivatives as modulators of ion channels
AU2006247478A1 (en) * 2005-05-16 2006-11-23 Vertex Pharmaceuticals Incorporated Bicyclic derivatives as modulators of ion channels
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
KR20080019693A (ko) * 2005-06-09 2008-03-04 버텍스 파마슈티칼스 인코포레이티드 이온 채널 조절인자로서의 인단 유도체
CN101300253B (zh) * 2005-09-09 2012-08-22 沃泰克斯药物股份有限公司 作为电压门控离子通道调控剂的二环衍生物
US7683083B2 (en) * 2005-10-12 2010-03-23 Vertex Pharmaceuticals Incorporated Biphenyl derivatives as modulators of voltage gated ion channels
JP2009512717A (ja) * 2005-10-21 2009-03-26 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルを調節するための誘導体
US7799822B2 (en) * 2005-12-21 2010-09-21 Vertex Pharmaceuticals Incorporated Phenyl sulfonamides as modulators of ion channels
MX2010005307A (es) * 2007-11-13 2010-07-28 Vertex Pharma Derivados heterociclicos como moduladores de canales de iones.
MX2010005309A (es) * 2007-11-13 2010-06-25 Vertex Pharma Derivados de 4-(3-(2-(fenil)morfolino)-2-oxopirrolidin-1-il-n-(tia zol-2-il)bencensulfonamida y compuestos relacionados como moduladores de canales ionicos para el tratamiento del dolor.
US7846954B2 (en) * 2008-07-01 2010-12-07 Vertex Pharmaceuticals Incorporated Heterocyclic derivatives as modulators of ion channels

Also Published As

Publication number Publication date
US20090105271A1 (en) 2009-04-23
US7994174B2 (en) 2011-08-09
EP2201008A1 (en) 2010-06-30
CA2699892A1 (en) 2009-03-26
JP2010539244A (ja) 2010-12-16
CN101842372A (zh) 2010-09-22
AU2008302205A1 (en) 2009-03-26
WO2009039328A1 (en) 2009-03-26
NZ584009A (en) 2012-03-30

Similar Documents

Publication Publication Date Title
MX2010003009A (es) Piridil sulfonamidas como moduladores de canales ionicos.
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
WO2010002956A3 (en) Heterocyclic derivatives as modulators of ion channels
IL187382A0 (en) Bicyclic derivatives as modulators of ion channels
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
NO20080141L (no) Indanderivater som modulatorer av ionekanaler
PH12016500105A1 (en) Sulfonamides as modulators of sodium channels
NO20071742L (no) Kinazoliner som er nyttige som modulatorer av ionekanaler
ZA201003352B (en) Heterocyclic derivatives as modulators of ion channels
MX2010003864A (es) Amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
MX355907B (es) Pirrolopirazina-piperidina espirociclica-amidas como moduladores de canales de ionicos.
MX2010003865A (es) Aril amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
MX2010003866A (es) Heteroaril amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
MX2013009393A (es) Piperidinamidas cromano-espirociclicas como moduladores de canales de iones.
NO20060518L (no) Pyrimidiner nyttige som modulatorer av spenningsstyrte ionekanaler
WO2014120808A8 (en) Pyridone amides as modulators of sodium channels
MX2010005309A (es) Derivados de 4-(3-(2-(fenil)morfolino)-2-oxopirrolidin-1-il-n-(tia zol-2-il)bencensulfonamida y compuestos relacionados como moduladores de canales ionicos para el tratamiento del dolor.
MX2015009591A (es) Amidas como moduladores de canales de sodio.
MX347982B (es) Morfolina-piperidina espirociclica-amidas como moduladores de canales ionicos.
MX2019005232A (es) Derivados de piperidin-4-il azetidina como inhibidores de janus cinasa 1 (jak1).
WO2007058989A3 (en) Quinazolines useful as modulators of voltage gated ion channels
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2010003563A (es) Inhibidores de proteina cinasa de c-met.
WO2006130493A8 (en) Heterocycles useful as modulators of ion channels

Legal Events

Date Code Title Description
FG Grant or registration